IBEX Preclinical Research

IBEX has established itself as a trusted partner in preclinical medical device research, leveraging over 20 years of experience. Our commitment to quality and integrity has positioned us as leaders in preclinical medical device testing. We specialize in a range of therapeutic areas, including orthopedics, wound care, ophthalmology, cardiovascular, gastrointestinal, and implant toxicity. Additionally, we offer non-surgical studies, such as nonsurgical drug toxicity and pharmacokinetic studies, to support a comprehensive understanding of device performance and safety. IBEX is a fully accredited, GLP compliant facility offering the highest quality and expertise. Our team of experienced veterinary surgeons and research associates ensures...

Preclinical studies,orthopedic studies,ophthalmology,dental,wound healing,cardiovascular/peripheral vascular,neuromodulation,and gastrointestinal

Ibex preclinical research operates in the Research industry.

Ibex preclinical research's revenue is 11m - 100m

Ibex preclinical research has 11 - 50 employees.